Endometrial angiogenesis

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 14, Issue 6, 2000, Pages 919-936

  Weston, Gareth ^a   Rogers, Peter A W ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiogenesis; Endometrium, VEGF, oestrogen, Progesterone

Indexed keywords

ANGIOPOIETIN; ANGIOSTATIN; ENDOSTATIN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; GROWTH INHIBITOR; GROWTH PROMOTOR; INTEGRIN; LEPTIN; LEVONORGESTREL; MATRIX METALLOPROTEINASE; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; DRUG IMPLANT; DRUG INHIBITION; EDEMA; ENDOMETRIOSIS; ENDOMETRIUM; HORMONE RECEPTOR INTERACTION; HUMAN; MENSTRUAL CYCLE; NONHUMAN; OVARY CYCLE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; SOLID TUMOR; TISSUE GROWTH; UTERUS GROWTH;

EID: 0034493080     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2000.0135     Document Type: Article

References (125)

1. Mechanisms of angiogenesis
2. Angiogenic factors
3. Angiogenesis in the human reproductive tract
4. Menstruation: Induction by matrix metalloproteinases and inflammatory cells
5. Menstruation in intraocular endometrial transplants in the rhesus monkey
6. Endometrial blood flow measured by xenon 133 clearance in women with normal menstrual cycles and dysfunctional uterine bleeding
7. Endometrial perfusion across the normal human endometrial cycle assessed by laser Doppler fluxmetry
8. A novel mechanism of capillary growth in the rat pulmonary microcirculation
9. Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic study
10. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
11. Endometrial microvascular growth in normal and dysfunctional states
12. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle
13. Endometrial endothelial cell proliferation during the menstrual cycle
14. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans
15. Expression of oestrogen receptor-α and β in ovarian endometriomata
16. Immunolocalisation of oestrogen receptor beta in human tissues
17. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors
18. Immunohistochemical localisation of receptors for progesterone and oestradiol-17β in the implantation site of the rhesus monkey
19. Progesterone regulates proliferation of endothelial cells
20. Vascular endothelial growth factor (VEGF) and its receptors
21. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
22. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization
23. Vascular endothelial growth factor is a secreted angiogenic mitogen
24. Vascular permeability factor, an endothelial cell mitogen related to PDGF
25. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3
26. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
27. The vascular endothelial growth factor family - Identification of a fourth molecular species and characterization of alternative splicing of RNA
28. Isolation of a human placental cDNA coding for a protein related to the vascular permeability factor
29. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
30. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
31. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
32. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
33. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
34. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor
35. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
36. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors
37. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
38. Comparison of expression patterns for placental growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
39. The biology of vascular endothelial growth factor
40. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
41. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
42. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect
43. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
44. The vascular endothelial growth factor receptor Flt-1 mediates biological activities
45. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
46. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
47. Vascular endothelial growth factor and its receptors in male fertility
48. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1
49. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells
50. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor 1
51. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumour angiogenesis
52. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau Protein
53. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells
54. Mutant p53 protein kinase C induction of vascular endothelial growth factor expression
55. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes
56. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
57. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells
58. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway
59. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells
60. Transforming growth factor β1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells
61. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
62. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically
63. The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges
64. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
65. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium
66. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells
67. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium
68. Immunolocalisation of vascular endothelial growth factor in human endometrium
69. Vascular endothelial growth factor expression in cycling human endometrium
70. Vectoral secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells
71. Expression of vascular endothelial growth factor receptors in the human endometrium: Modulation during the menstrual cycle
72. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium
73. VEGF, its receptors and the Tie receptors in recurrent miscarriage
74. Structural characterization and biological functions of fibroblast growth factor
75. Biological roles of fibroblast growth factor-2
76. Purification and characterization of a functional soluble fibroblast growth factor receptor 1
77. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3
78. Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium
79. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction
80. Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma
81. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: Localization and expression of basic fibroblast growth factor and FGF-RI in human endometrium during the menstrual cycle and decreased FGF-RI expression in menorrhagia
82. Fibroblast growth factors 1 and 2 in the primate uterus
83. Inhibition of progesterone receptor function results in loss of basic fibroblast growth factor expression and stromal cell proliferation during uterine remodelling in the pregnant rat
84. Macrophase-induced angiogenesis is mediated by tumour necrosis factor-α
85. Expression of tumor necrosis factor-α and its mRNA in the endometrial mucosa during the menstrual cycle
86. Tumour necrosis factor-α (TNF-α) in human endometrium and uterine secretion: An evaluation by immunohistochemistry, ELISA and semiquantitative RT-PCR
87. Regulation of the expression of the angiogenic enzyme platelet-derived endothelial growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines
88. Biological action of leptin as an angiogenic factor
89. Leptin in human reproduction
90. Estrogen increases in vivo leptin production in rats and human subjects
91. Mapsin, a serpin with tumor-suppressing activity in human mammary epithelial cells
92. Mapsin is an angiogenesis inhibitor
93. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
94. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
95. Thrombospondin-I, an inhibitor of angiogenesis, is segulated by progesterone in the human endometrium
96. METH-I, a human ortholog of ADAMTS-I, and METH-2 are members of a new family of proteins with angio-inhibitory activity
97. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment
98. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
99. 2-Methoxygestradiol, an endogenous metabolite of estrogen, enhances apoptosis and β-galactosidase expression in vascular endothelial cells
100. Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol
101. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
102. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
103. Kringle domains of human angiostatin
104. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
105. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
106. Collagen XVII is a basement membrane heparin sulfate proteoglycan
107. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
108. Changes in vascular basement membrane in the endometrium of Norplant users
109. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischaemia
110. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation
111. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
112. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470
113. Blood vessel maturation: Vascular development comes of age
114. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
115. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
116. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
117. Leakage resistant blood vessels in mice transgenically overexpressing angiopoietin-1
118. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: A receptor ligand model for vascular remodelling
119. Analysis of blood vessel maturation processes during ovarian angiogenesis
120. PDGF, TGFβ, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate
121. Transforming growth factor-beta 1 in the human endometrium
122. 3 for angiogenesis
123. v integrins
124. Endometrial vascular and glandular expression of integrin alpha(v) beta3 in women with and without endometriosis
125. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium